Grant Funded Startups in Israel
Across these 14 Israel grant rounds, the largest disclosed amount is BELKIN Vision’s $20M (2021-12-20).
Across these 14 Israel grant rounds, the largest disclosed amount is BELKIN Vision’s $20M (2021-12-20). It stands apart from the rest of the disclosed figures, where most amounts cluster below $2M (for example, MediWound at $2M on 2022-02-17 and the $200K–$1M range appears multiple times such as Donisi Health at $200K on 2021-12-08). The smallest disclosed amount is Zoog’s $10K (2022-08-09), below the $30K floor seen elsewhere (e.g., Kinoko-Tech $30K on 2022-06-15).
The rounds also show a tight temporal cluster: 9 of the 14 entries fall between 2022-02-17 (MediWound) and 2022-09-07 (Azura Ophthalmics). Geographically, Tel Aviv appears frequently (Azura Ophthalmics, Zoog, Kardome, SuperMeat, AbiliSense), while other cities/areas are less represented (e.g., Yavne for MediWound and BELKIN Vision; Jerusalem for Omnix Medical). In sectors, Biotechnology is the most common category with 4 entries (Azura Ophthalmics, SuperMeat, MediWound, Donisi Health). Amount disclosure is uneven: 3 of 14 rounds are undisclosed (Azura Ophthalmics on 2022-09-07; Sanolla on 2022-06-08; SuperMeat on 2022-06-08).
Most recent rounds
14 shownRelated listings
Frequently asked
What looks most like a “top-heavy” pattern in disclosed grant sizes, and where does the distribution break?
BELKIN Vision’s $20M (2021-12-20) is the only disclosed round above $10M in this set; the next-largest disclosed amounts are REE Automotive at $17M (2021-08-20) and Omnix Medical at $13M (2021-01-25), while several others sit at $2M or below (e.g., MediWound $2M on 2022-02-17; Donisi Health $200K on 2021-12-08).
Do the most recent rounds cluster tightly in time, or are they spread out?
They cluster: 9 of 14 entries have round dates between 2022-02-17 (MediWound) and 2022-09-07 (Azura Ophthalmics). The listing spans from the oldest shown date, 2021-01-25 (Omnix Medical), to the most recent shown date, 2022-09-07 (Azura Ophthalmics).
Which sectors are over-represented relative to the rest of the list?
Biotechnology is the clear concentration at 4 of 14 entries (Azura Ophthalmics on 2022-09-07, SuperMeat on 2022-06-08, MediWound on 2022-02-17, Donisi Health on 2021-12-08). Other sectors appear once or twice, such as AI (AbiliSense, 2021-11-01) and Transportation (REE Automotive, 2021-08-20).
Is there a city-level concentration, especially around Tel Aviv versus other locations?
Tel Aviv-anchored listings are frequent: Azura Ophthalmics (Tel Aviv, 2022-09-07), Zoog (Tel Aviv, 2022-08-09), Kardome (Tel Aviv-yafo, 2022-06-20), SuperMeat (Tel Aviv, 2022-06-08), and AbiliSense (Tel Aviv-yafo, 2021-11-01). Other cities are comparatively sparse, such as Jerusalem for Omnix Medical (2021-01-25) and Yavne for MediWound (2022-02-17) and BELKIN Vision (2021-12-20).
Are undisclosed amounts a significant pattern, and do they affect outlier detection?
3 of 14 rounds are undisclosed (Azura Ophthalmics on 2022-09-07; Sanolla on 2022-06-08; SuperMeat on 2022-06-08). Because the largest disclosed figure is BELKIN Vision’s $20M (2021-12-20), undisclosed entries limit confidence on whether any “hidden” outliers sit above the disclosed top end.
Which rounds fall into the later part of the listing window (useful for outbound targeting)?
The later dates include Zoog at $10K (2022-08-09) and Azura Ophthalmics (undisclosed) at 2022-09-07, with several additional 2022 grants in between: Driivz $100K (2022-06-20), Kardome $100K (2022-06-20), and Kinoko-Tech $30K (2022-06-15). Earlier vintages also appear, such as Omnix Medical at $13M (2021-01-25) and REE Automotive at $17M (2021-08-20).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.